2NevilleF, KennethC, Lasseter, et al. Single-Dose and steady-state pharmacokinetics of Fosinopril and Fosinoprilat in patients with Hepatic Impairment[J]. J Clin Pharmacol,1995, 35:145-150.
4M Lomgardo M, Alli C, Broccolino et al. Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension[J]. Am Heart J, 1997, 134:557-564.
5Waldemar G, Ibsen H, Strandgaard S, et al. The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension[J] Am J Hypertens, 1990, 3:464-470.
6Duchin KL, Waclawsk al. Pharmacokinetics pharmacologic effects sodium, an angioters enzyme inhibitor i AP, Tu JI,et , safety, and of fosinopril in-converting in health subjects[J]. J Clin Pharmacol, 1999, 31:58 - 64.
